Study characterizes multisystem inflammatory syndrome in adults

Study characterizes multisystem inflammatory syndrome in adults

(HealthDay)—Multisystem inflammatory syndrome in adults (MIS-A) presents about four weeks postacute COVID-19 with heterogeneous clinical symptoms, according to research published online Sept. 22 in JAMA Network Open.

Pragna Patel, M.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues conducted a to identify reports of MIS-A either in the literature or from the U.S. Centers for Disease Control and Prevention surveillance system.

The researchers identified 221 patients with MIS-A (median age, 21 years; 70 percent men). Just over one-third of cases (36 percent) were non-Hispanic Black individuals, and 58 percent had no underlying comorbidity. More than two-thirds (68 percent) noted a previous symptomatic COVID-19-like illness a median of 28 days previously. Most common presentations included fever (96 percent), hypotension (60 percent), cardiac dysfunction (54 percent), shortness of breath (52 percent), and diarrhea (52 percent). Cases had a median of five organ systems involved and had a median hospital stay of eight days. More than half of cases (57 percent) were admitted to the , with 47 percent requiring respiratory support and 7 percent dying. The majority of patients (90 percent) had elevated markers of coagulopathy and/or inflammation and a positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serologic finding (72 percent).

"It is important for the clinical and public health community to suspect and identify MIS-A, a delayed immunologic response to SARS-CoV-2 infection in adults with hyperinflammation, by exercising clinical acumen and considering empirical treatment to reduce related morbidity and mortality," the authors write.


Explore further

CDC updates info on multisystem inflammatory syndrome in children

More information: Abstract/Full Text
Journal information: JAMA Network Open

Copyright © 2021 HealthDay. All rights reserved.

Citation: Study characterizes multisystem inflammatory syndrome in adults (2021, September 30) retrieved 29 November 2021 from https://medicalxpress.com/news/2021-09-characterizes-multisystem-inflammatory-syndrome-adults.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
14 shares

Feedback to editors